Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc. (DYN) priced its initial public offering on Sep 17, 2020 at $19.00 per share, above its $16.00–$18.00 range, raising $232.8M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $828.1M. Piper Sandler was lead-left underwriter, joined by J.P. Morgan, Jefferies and Stifel. WilmerHale advised the company and Cooley advised the underwriters.

Status

IPO

Ticker

DYN

Exchange

Nasdaq Global Select

Priced

Sep 17, 2020

IPO price

$19.00

Price range

$16.00–$18.00

Raised

$232.8M

Market cap at IPO price

$828.1M

First filed

Aug 25, 2020

Underwriters

Piper Sandler, J.P. Morgan, Jefferies and Stifel

Company counsel

WilmerHale

Underwriters' counsel

Cooley

Sector

Biotech & pharma

Country / state

MA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.